133 related articles for article (PubMed ID: 12458827)
1. Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment.
Duke BO; Marty AM; Peett DL; Gardo J; Pion SD; Kamgno J; Boussinesq M
Parasitology; 2002 Nov; 125(Pt 5):431-44. PubMed ID: 12458827
[TBL] [Abstract][Full Text] [Related]
2. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
3. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
[TBL] [Abstract][Full Text] [Related]
4. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.
Gardon J; Boussinesq M; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO
Lancet; 2002 Jul; 360(9328):203-10. PubMed ID: 12133654
[TBL] [Abstract][Full Text] [Related]
5. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786
[TBL] [Abstract][Full Text] [Related]
6. Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.
Campillo JT; Chesnais CB; Pion SDS; Gardon J; Kamgno J; Boussinesq M
Parasit Vectors; 2020 May; 13(1):258. PubMed ID: 32414398
[TBL] [Abstract][Full Text] [Related]
7. How long do the effects of ivermectin on adult Onchocerca volvulus persist?
Kläger S; Whitworth JA; Post RJ; Chavasse DC; Downham MD
Trop Med Parasitol; 1993 Dec; 44(4):305-10. PubMed ID: 8134772
[TBL] [Abstract][Full Text] [Related]
8. The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone.
Chavasse DC; Post RJ; Lemoh PA; Whitworth JA
Trop Med Parasitol; 1992 Dec; 43(4):256-62. PubMed ID: 1293732
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
Pion SD; Nana-Djeunga HC; Kamgno J; Tendongfor N; Wanji S; Njiokou F; Prichard RK; Boussinesq M
PLoS Negl Trop Dis; 2013; 7(2):e2084. PubMed ID: 23469307
[TBL] [Abstract][Full Text] [Related]
10. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
11. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus.
Bourguinat C; Ardelli BF; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
Mol Biochem Parasitol; 2008 Apr; 158(2):101-11. PubMed ID: 18215431
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
14. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
15. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
16. Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin.
Duke BO; Pacqué MC; Muñoz B; Greene BM; Taylor HR
Bull World Health Organ; 1991; 69(2):163-8. PubMed ID: 1860146
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M
Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.
Fobi G; Gardon J; Kamgno J; Aimard-Favennec L; Lafleur C; Gardon-Wendel N; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2005 Apr; 99(4):279-89. PubMed ID: 15708387
[TBL] [Abstract][Full Text] [Related]
19. Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin.
Chavasse DC; Post RJ; Davies JB; Whitworth JA
Trop Med Parasitol; 1993 Sep; 44(3):155-8. PubMed ID: 8256088
[TBL] [Abstract][Full Text] [Related]
20. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
